FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039464914> ?p ?o ?g. }

• W2039464914 endingPage "1006.e15" @default.
• W2039464914 startingPage "1006.e9" @default.
• W2039464914 abstract "Objectives To evaluate the effect of a Cannabis sativa extract enriched in cannabidiol (CBD) botanic drug substance (BDS) and pure CBD, on bladder contractility in vitro. Cannabis based-medicines, including CBD-enriched extracts, have been shown to reduce urinary urgency, incontinence episodes, frequency, and nocturia in patients with multiple sclerosis. Methods Strips were cut from male Wistar rats and the human bladder body and placed in organ baths containing Krebs solution. Contractions were induced by electrical field stimulation, acetylcholine, KCl, and α,β-methylene adenosine triphosphate. Results CBD BDS significantly reduced the contractions induced by acetylcholine, but not those induced with electrical field stimulation, KCl, or α,β-methylene adenosine triphosphate in the isolated rat bladder. The inhibitory effect of CBD BDS was not significantly modified by the cannabinoid or opioid receptor antagonists or by modulators of calcium levels, but it was increased by ruthenium red and capsazepine, 2 transient receptor potential vanilloid type-1 blockers. In humans, CBD BDS and pure CBD significantly reduced acetylcholine-induced contractions, an effect that was not changed by the transient receptor potential vanilloid type-1 blockers. Conclusions Our data have suggested that CBD BDS reduces cholinergic-mediated contractility and that this effect is modulated by transient receptor potential vanilloid type-1 in rats but not in humans. CBD is the chemical ingredient of CBD BDS responsible for such activity. If confirmed in vivo, such results could provide a pharmacologic basis to explain, at least in part, the efficacy of Cannabis medicines in reducing incontinence episodes in patients with multiple sclerosis. To evaluate the effect of a Cannabis sativa extract enriched in cannabidiol (CBD) botanic drug substance (BDS) and pure CBD, on bladder contractility in vitro. Cannabis based-medicines, including CBD-enriched extracts, have been shown to reduce urinary urgency, incontinence episodes, frequency, and nocturia in patients with multiple sclerosis. Strips were cut from male Wistar rats and the human bladder body and placed in organ baths containing Krebs solution. Contractions were induced by electrical field stimulation, acetylcholine, KCl, and α,β-methylene adenosine triphosphate. CBD BDS significantly reduced the contractions induced by acetylcholine, but not those induced with electrical field stimulation, KCl, or α,β-methylene adenosine triphosphate in the isolated rat bladder. The inhibitory effect of CBD BDS was not significantly modified by the cannabinoid or opioid receptor antagonists or by modulators of calcium levels, but it was increased by ruthenium red and capsazepine, 2 transient receptor potential vanilloid type-1 blockers. In humans, CBD BDS and pure CBD significantly reduced acetylcholine-induced contractions, an effect that was not changed by the transient receptor potential vanilloid type-1 blockers. Our data have suggested that CBD BDS reduces cholinergic-mediated contractility and that this effect is modulated by transient receptor potential vanilloid type-1 in rats but not in humans. CBD is the chemical ingredient of CBD BDS responsible for such activity. If confirmed in vivo, such results could provide a pharmacologic basis to explain, at least in part, the efficacy of Cannabis medicines in reducing incontinence episodes in patients with multiple sclerosis." @default.
• W2039464914 created "2016-06-24" @default.
• W2039464914 creator A5002541055 @default.
• W2039464914 creator A5013018244 @default.
• W2039464914 creator A5014614796 @default.
• W2039464914 creator A5018950625 @default.
• W2039464914 creator A5043867481 @default.
• W2039464914 creator A5049123139 @default.
• W2039464914 creator A5059461366 @default.
• W2039464914 creator A5076221297 @default.
• W2039464914 creator A5086116359 @default.
• W2039464914 date "2011-04-01" @default.
• W2039464914 modified "2023-09-26" @default.
• W2039464914 title "Inhibitory Effect of Standardized Cannabis sativa Extract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility" @default.
• W2039464914 cites W1965004534 @default.
• W2039464914 cites W1967922769 @default.
• W2039464914 cites W1975572244 @default.
• W2039464914 cites W1976848876 @default.
• W2039464914 cites W2016729070 @default.
• W2039464914 cites W2022872914 @default.
• W2039464914 cites W2024255262 @default.
• W2039464914 cites W2024424546 @default.
• W2039464914 cites W2025896506 @default.
• W2039464914 cites W2027706303 @default.
• W2039464914 cites W2032288100 @default.
• W2039464914 cites W2040738328 @default.
• W2039464914 cites W2042745063 @default.
• W2039464914 cites W2046955207 @default.
• W2039464914 cites W2058766482 @default.
• W2039464914 cites W2063269320 @default.
• W2039464914 cites W2064080385 @default.
• W2039464914 cites W2068382277 @default.
• W2039464914 cites W2078291595 @default.
• W2039464914 cites W2078596607 @default.
• W2039464914 cites W2079357599 @default.
• W2039464914 cites W2090616264 @default.
• W2039464914 cites W2094323845 @default.
• W2039464914 cites W2094326590 @default.
• W2039464914 cites W2100181368 @default.
• W2039464914 cites W2101233587 @default.
• W2039464914 cites W2110331119 @default.
• W2039464914 cites W2110690684 @default.
• W2039464914 cites W2112303081 @default.
• W2039464914 cites W2144783337 @default.
• W2039464914 cites W2158518114 @default.
• W2039464914 cites W2168111104 @default.
• W2039464914 cites W2168508981 @default.
• W2039464914 doi "https://doi.org/10.1016/j.urology.2010.12.006" @default.
• W2039464914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21310467" @default.
• W2039464914 hasPublicationYear "2011" @default.
• W2039464914 type Work @default.
• W2039464914 sameAs 2039464914 @default.
• W2039464914 citedByCount "20" @default.
• W2039464914 countsByYear W20394649142012 @default.
• W2039464914 countsByYear W20394649142013 @default.
• W2039464914 countsByYear W20394649142014 @default.
• W2039464914 countsByYear W20394649142015 @default.
• W2039464914 countsByYear W20394649142016 @default.
• W2039464914 countsByYear W20394649142018 @default.
• W2039464914 countsByYear W20394649142020 @default.
• W2039464914 countsByYear W20394649142021 @default.
• W2039464914 countsByYear W20394649142022 @default.
• W2039464914 countsByYear W20394649142023 @default.
• W2039464914 crossrefType "journal-article" @default.
• W2039464914 hasAuthorship W2039464914A5002541055 @default.
• W2039464914 hasAuthorship W2039464914A5013018244 @default.
• W2039464914 hasAuthorship W2039464914A5014614796 @default.
• W2039464914 hasAuthorship W2039464914A5018950625 @default.
• W2039464914 hasAuthorship W2039464914A5043867481 @default.
• W2039464914 hasAuthorship W2039464914A5049123139 @default.
• W2039464914 hasAuthorship W2039464914A5059461366 @default.
• W2039464914 hasAuthorship W2039464914A5076221297 @default.
• W2039464914 hasAuthorship W2039464914A5086116359 @default.
• W2039464914 hasConcept C118552586 @default.
• W2039464914 hasConcept C126322002 @default.
• W2039464914 hasConcept C134018914 @default.
• W2039464914 hasConcept C142724271 @default.
• W2039464914 hasConcept C170493617 @default.
• W2039464914 hasConcept C204787440 @default.
• W2039464914 hasConcept C22885893 @default.
• W2039464914 hasConcept C24998067 @default.
• W2039464914 hasConcept C2775910092 @default.
• W2039464914 hasConcept C2776895053 @default.
• W2039464914 hasConcept C2777056318 @default.
• W2039464914 hasConcept C2778941218 @default.
• W2039464914 hasConcept C2780871563 @default.
• W2039464914 hasConcept C71924100 @default.
• W2039464914 hasConcept C98274493 @default.
• W2039464914 hasConceptScore W2039464914C118552586 @default.
• W2039464914 hasConceptScore W2039464914C126322002 @default.
• W2039464914 hasConceptScore W2039464914C134018914 @default.
• W2039464914 hasConceptScore W2039464914C142724271 @default.
• W2039464914 hasConceptScore W2039464914C170493617 @default.
• W2039464914 hasConceptScore W2039464914C204787440 @default.
• W2039464914 hasConceptScore W2039464914C22885893 @default.
• W2039464914 hasConceptScore W2039464914C24998067 @default.
• W2039464914 hasConceptScore W2039464914C2775910092 @default.
• W2039464914 hasConceptScore W2039464914C2776895053 @default.

• next